Clinical Trials for Cancer Treatment " Benefits and Options
Links shared publicly online about this topic.
- 1,140total visits
Clinical Trials for Cancer Treatment " Benefits and Options
View full resource at cancer.suite101.com
Tags: Cancer, Clinical Trial
Most Recently Shared on May 26, 2010 at 5:06 pm By:
Clinical Trials for Cancer Treatment -- Benefits and Options: Participating in a cancer trial can maximize positiv... http://bit.ly/bn7EP6
Clinical trials: A treatment option to think about - ONA
oncologynurseadvisor.com — “Patients bombarded with information may find it difficult to understand another treatment option: clinical trials. This article explains the concept and defines common terms.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 26, 2012 at 10:45 pm By:
OncologyNurseAdvisor Nursing, Medical Education, Medical Publisher, and Oncology
For your patients: Clinical trials: A treatment option to think about http://t.co/tcUsXHHa #ClinicalTrials #Cancer
Flaxseed No Help For Hot Flashes During Breast Cancer Or Menopause, Study Finds
medicalnewstoday.com — “A study by Mayo Clinic physician and North Central Cancer Treatment Group (NCCTG) researcher Sandhya Pruthi, M.D., and colleagues found that flaxseed provided no benefit in easing hot flashes amon” View full resource at medicalnewstoday.com
Most Recently Shared on September 8, 2011 at 11:05 am By:
Monica Reinagel Health Professional
Bummer: Preliminary evidence that flax seeds might help curb hot flashes fails to hold up in a larger trial. http://ow.ly/6oRKx
What criteria do you follow in deciding to use high dose rate brachytherapy for breast cancer?
talkabouthealth.com — “The use of radiation therapy has been a standard treatment option for women undergoing lumpectomy since publication of NSABP B-06, a clinical trial conducted ab” View full resource at talkabouthealth.com
Most Recently Shared on August 18, 2011 at 5:02 pm By:
Amazing answer! MT @subatomicdoc Criteria do you follow deciding to use high dose rate brachytherapy fr breast cancer? http://t.co/wd1RKmY
NIH-funded study shows reduction in death for men with intermediate-grade prostate cancer, July 13, 2011 News Release - National Institutes of Health (NIH)
nih.gov — “Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly to patients with intermediate-risk disease and were not seen for men with low-risk prostate cancer, researchers say. T” View full resource at nih.gov
Most Recently Shared on July 13, 2011 at 10:25 pm By:
Matthew Katz Doctor, Oncologist, Radiation Oncologist, and Physician
RT @NIHforHealth: News: NIH-funded study shows reduction in death for men with intermediate-grade prostate #cancer http://1.usa.gov/oa3tiF
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate(R) Non-Invasive Prostate Cancer System - Health News - redOrbit
redorbit.com — “TIRAT CARMEL, Israel, July 13, 2011 /PRNewswire/ -- Initial Results are Encouraging, Spurring Hope for a Treatment Option With a Lower Rate of Complications InSightec Ltd., the global leader in MR-guided focused ultrasound technology and the only company to receive FDA approval for its ExAblate(R) system for treating uterine fibroids, announced today that 23 patients with organ confined low risk prostate cancer have already been treated with its ExAblate(R) system in clinical trials, showing pro” View full resource at redorbit.com
Most Recently Shared on July 13, 2011 at 5:48 pm By:
Urology & Nephrology OW Health
23 Patients With Organ Confined Low Risk Prostate Cancer Have Been Treated in Clinical Trials Using the ExAblate... http://bit.ly/qwJIsc
ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed Ovarian Cancer - MPR
empr.com — “The addition of bevacizumab to carboplatin and paclitaxel chemotherapy for the first-line treatment of women with ovarian cancer may offer benefit compared with standard chemotherapy alone, particularly for patients with more aggressive disease, investigators noted in a presentation during the American Society of Clinical Oncology’s 2011 Annual Meeting.” View full resource at empr.com
Most Recently Shared on June 5, 2011 at 5:52 pm By:
#asco2011 ICON7 Trial Shows Bevacizumab Increases Survival in Women with Newly Diagnosed… http://goo.gl/fb/a5CpE
Heart failure treatment options have come a long way
eurekalert.org — “Highlights of the late breaking trials and clinical updates program will include the SHIFT trial with ivadrabine, EMPHASIS-HF with eplerenone, an update on the MADIT CRT trial on how to predict optimal benefits from CRT, Northstar, and two telemonitoring trials -- the TEHAF study and TIM-HF.” View full resource at eurekalert.org
Most Recently Shared on May 5, 2011 at 8:24 pm By:
Heart failure treatment options have come a long way: ( European Society of Cardiology ) Highlights of the late ... http://bit.ly/miKIXR
Guest commentary: Prostate article underestimates treatment benefit » Marco Eagle
marconews.com — “As a practicing medical oncologist with a background in clinical trial design for prostate cancer, I read with great interest the recent Associated Press story, 'Medicare Agrees to Pay for $93,000 Prostate Cancer Drug.'” View full resource at marconews.com
Most Recently Shared on April 5, 2011 at 4:56 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
Guest commentary: Prostate article underestimates treatment benefit: As a practicing medical oncologist with a b... http://bit.ly/eH5rhg
LIVESTRONG.org -
nexprofiler.nexcura.com — “Use our free Cancer Profiler Tools. Get personalized treatment descriptions, side effects, questions for your doctor, pros and cons, and medical literature. Learn about treatment options such as chemotherapy, surgery, hormone therapy, radiation therapy, clinical trials, and best supportive care.” View full resource at nexprofiler.nexcura.com
Most Recently Shared on March 14, 2011 at 2:38 pm By:
Great tool on our site that helps people make tx decisions. http://bit.ly/txdecisions Also gives pros/cons and side effects.
amednews: Oncologists shouldn't delay frank talk with patients :: Feb. 14, 2011 ... American Medical News
ama-assn.org — “Candid conversations about treatment options and palliative care benefit patients most, says the American Society of Clinical Oncology.” View full resource at ama-assn.org
Most Recently Shared on February 14, 2011 at 3:48 pm By:
Oncologists shouldn't delay frank talk with patients http://bit.ly/gYb7we
Medical News: Cancer Trial Patients Take Rosy View of Likely Benefit - in Public Health & Policy, Clinical Trials from MedPage Today
medpagetoday.com — “Patients in early-trials of novel cancer treatments overestimate the likelihood that they personally will benefit from the treatment, for reasons that additional pretrial education may not overcome, r” View full resource at medpagetoday.com
Most Recently Shared on January 28, 2011 at 8:30 pm By:
Wafik El-Deiry MD, PhD Physician, Doctor, PhD, Internist, Oncologist, and Hematologist
Complex Reality: Cancer Trial Patients Take Rosy View of Likely Benefit from MedPage Today http://t.co/7vRMZVC ethics & unrealistic optimism
Medical News: Cancer Trial Patients Take Rosy View of Likely Benefit - in Public Health & Policy, Clinical Trials from MedPage Today
medpagetoday.com — “Patients in early-trials of novel cancer treatments overestimate the likelihood that they personally will benefit from the treatment, for reasons that additional pretrial education may not overcome, r” View full resource at medpagetoday.com
Most Recently Shared on January 28, 2011 at 12:37 am By:
Cancer Trial Patients Take Rosy View of Likely Benefit (CME/CE) http://bit.ly/i9Edhw
Genentech Personalized Investigational Medicine Shows Survival Benefit In Advanced Skin Cancer
medicalnewstoday.com — “Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that BRIM3, a Phase III clinical study of RG7204 (PLX4032), met its co-primary endpoints showing a significant survi” View full resource at medicalnewstoday.com
Most Recently Shared on January 20, 2011 at 2:05 pm By:
MNT Dermatology News Dermatology and Health News
Genentech Personalized Investigational Medicine Shows Survival Benefit In Advanced Skin Cancer http://mnt.to/3Qcj #dermatology
Historic TAILORx Breast Cancer Clinical Trial Reaches Patient Accrual Goal
prweb.com — “Are some women with breast cancer being over-treated with chemotherapy? Breast cancer experts are completing an important milestone this month in their research to answer this question, as they complete accrual of over 10,000 women with early stage breast cancer to the TAILORx clinical trial. TAILORx or "Trial Assigning IndividuaLized Options for Treatment (Rx)", is a clinical research trial for women with early-stage breast cancer.” View full resource at prweb.com
Most Recently Shared on December 1, 2010 at 3:12 am By:
David Flores - Einstein College of Medicine Medical School
More on TailorX #breast cancer trial. http://bit.ly/fd9P1K Einstein-Montefiore doc says results could spare 20k women/yr fr chemo. #MDchat
Immunocore Announces Clinical Trials Of New Treatment For Advanced Melanoma In UK And USA - QualityPoint Technologies
qualitypointtech.net — “Researchers at Immunocore Limited announced that IMCgp100, a targeted therapeutic for the treatment of advanced metastatic melanoma, has received regulatory and ethics approval and has opened enrolment for clinical trials in the UK and USA. IMCgp100 is the first clinical candidate originating from Immunocore's innovative ImmTAC technology platform and a new treatment could benefit many thousands of patients diagnosed with skin cancer each year. Melanoma is a form of skin cancer that accounts for” View full resource at qualitypointtech.net
Most Recently Shared on October 6, 2010 at 3:24 pm By:
Immunocore Announces Clinical Trials Of New Treatment For Advanced Melanoma In UK And USA: Researchers at Immunoco... http://bit.ly/c2Iaih
Advertisement
